Heather K Neilson1, Megan S Farris, Chelsea R Stone, Marcus M Vaska, Darren R Brenner, Christine M Friedenreich. 1. 1Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Calgary, Alberta, Canada 2Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada 3Knowledge Resource Service, Alberta Health Services, Calgary, Alberta, Canada 4Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Abstract
OBJECTIVE: Physical inactivity increases postmenopausal and possibly premenopausal breast cancer risk, although different biologic mechanisms are proposed. Our primary objective was to estimate breast cancer risk associated with high versus low levels of moderate-vigorous recreational activity, separately for premenopausal and postmenopausal women. METHODS: We conducted a systematic review of literature published to July 2015. Included reports were cohort or case-control studies relating moderate-vigorous recreational physical activity (metabolic equivalent ≥3.0) to breast cancer incidence, exclusively (≥90%) in premenopausal or postmenopausal women. We appraised study quality and performed meta-analyses using random effects modeling. Subgroup meta-analyses were based on tumor subtype, race, body mass index, parity, hormone therapy use, family history of cancer, and statistical adjustment for body fatness. Dose-response relations were examined. RESULTS: Pooled relative risks (RRs, 95% CI) for women with higher versus lower levels of moderate-vigorous recreational activity were RR = 0.80 (0.74-0.87) and RR = 0.79 (0.74-0.84) for premenopausal (43 studies) and postmenopausal (58 studies) breast cancer, respectively, with high heterogeneity. Inverse associations were weaker among postmenopausal cohort studies (RR = 0.90 [0.85-0.95]) and studies that statistically adjusted for nonrecreational (eg, occupational, household) activity (RR = 0.91 [0.77-1.06] premenopausal, RR = 0.96 [0.86-1.08] postmenopausal). Risk estimates with versus without body fatness adjustment did not vary by menopause status, although other subgroup effects were menopause-dependent. Among studies of overweight/obese women, there was an inverse association with postmenopausal but not premenopausal breast cancer (RR = 0.88 [0.82-0.95] and RR = 0.99 [0.98-1.00], respectively). Dose-response curves were generally nonlinear. CONCLUSIONS: Although risk estimates may be similar for premenopausal and postmenopausal breast cancer, subgroup effects may be menopause-dependent.
OBJECTIVE: Physical inactivity increases postmenopausal and possibly premenopausal breast cancer risk, although different biologic mechanisms are proposed. Our primary objective was to estimate breast cancer risk associated with high versus low levels of moderate-vigorous recreational activity, separately for premenopausal and postmenopausal women. METHODS: We conducted a systematic review of literature published to July 2015. Included reports were cohort or case-control studies relating moderate-vigorous recreational physical activity (metabolic equivalent ≥3.0) to breast cancer incidence, exclusively (≥90%) in premenopausal or postmenopausal women. We appraised study quality and performed meta-analyses using random effects modeling. Subgroup meta-analyses were based on tumor subtype, race, body mass index, parity, hormone therapy use, family history of cancer, and statistical adjustment for body fatness. Dose-response relations were examined. RESULTS: Pooled relative risks (RRs, 95% CI) for women with higher versus lower levels of moderate-vigorous recreational activity were RR = 0.80 (0.74-0.87) and RR = 0.79 (0.74-0.84) for premenopausal (43 studies) and postmenopausal (58 studies) breast cancer, respectively, with high heterogeneity. Inverse associations were weaker among postmenopausal cohort studies (RR = 0.90 [0.85-0.95]) and studies that statistically adjusted for nonrecreational (eg, occupational, household) activity (RR = 0.91 [0.77-1.06] premenopausal, RR = 0.96 [0.86-1.08] postmenopausal). Risk estimates with versus without body fatness adjustment did not vary by menopause status, although other subgroup effects were menopause-dependent. Among studies of overweight/obesewomen, there was an inverse association with postmenopausal but not premenopausal breast cancer (RR = 0.88 [0.82-0.95] and RR = 0.99 [0.98-1.00], respectively). Dose-response curves were generally nonlinear. CONCLUSIONS: Although risk estimates may be similar for premenopausal and postmenopausal breast cancer, subgroup effects may be menopause-dependent.
Authors: Megan S Rice; Shelley S Tworoger; Susan E Hankinson; Rulla M Tamimi; A Heather Eliassen; Walter C Willett; Graham Colditz; Bernard Rosner Journal: Breast Cancer Res Treat Date: 2017-07-12 Impact factor: 4.872
Authors: Gundula Behrens; Thomas Gredner; Christian Stock; Michael F Leitzmann; Hermann Brenner; Ute Mons Journal: Dtsch Arztebl Int Date: 2018-09-03 Impact factor: 5.594
Authors: Rebecca D Kehm; Jeanine M Genkinger; Robert J MacInnis; Esther M John; Kelly-Anne Phillips; Gillian S Dite; Roger L Milne; Nur Zeinomar; Yuyan Liao; Julia A Knight; Melissa C Southey; Wendy K Chung; Graham G Giles; Sue-Anne McLachlan; Kristen D Whitaker; Michael Friedlander; Prue C Weideman; Gord Glendon; Stephanie Nesci; kConFab Investigators; Irene L Andrulis; Saundra S Buys; Mary B Daly; John L Hopper; Mary Beth Terry Journal: Cancer Res Date: 2019-10-02 Impact factor: 12.701
Authors: Somdat Mahabir; Walter C Willett; Christine M Friedenreich; Gabriel Y Lai; Carol J Boushey; Charles E Matthews; Rashmi Sinha; Graham A Colditz; Joseph A Rothwell; Jill Reedy; Alpa V Patel; Michael F Leitzmann; Gary E Fraser; Sharon Ross; Stephen D Hursting; Christian C Abnet; Lawrence H Kushi; Philip R Taylor; Ross L Prentice Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-12-18 Impact factor: 4.254
Authors: Yasuhiko Kubota; Kelly R Evenson; Richard F Maclehose; Nicholas S Roetker; Corinne E Joshu; Aaron R Folsom Journal: Med Sci Sports Exerc Date: 2017-08 Impact factor: 5.411
Authors: Alexandra J White; Dale P Sandler; Nicole M Niehoff; Hazel B Nichols; Shanshan Zhao Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-10-17 Impact factor: 4.254
Authors: Alpa V Patel; Christine M Friedenreich; Steven C Moore; Sandra C Hayes; Julie K Silver; Kristin L Campbell; Kerri Winters-Stone; Lynn H Gerber; Stephanie M George; Janet E Fulton; Crystal Denlinger; G Stephen Morris; Trisha Hue; Kathryn H Schmitz; Charles E Matthews Journal: Med Sci Sports Exerc Date: 2019-11 Impact factor: 5.411